Literature DB >> 10331600

Strong similarities of the FMR1 mutation in multiple tissues: postmortem studies of a male with a full mutation and a male carrier of a premutation.

F Tassone1, R J Hagerman, L W Gane, A K Taylor.   

Abstract

Studies of the FMR1 mutation in multiple tissues are important to further our understanding of CGG repeat expansion in development and of the frequency and possible clinical significance of inter-tissue heterogeneity in fragile X syndrome. With some exceptions, most cases reported have shown strong similarity of the mutation size and methylation status between tissues. However, there have been only a few studies of multiple tissues including regions of the brain. We report on two postmortem studies of multiple tissues, one of a male with a full mutation (fully methylated) and one of a male carrier of a premutation. The male with the full mutation (TH) had a typical presentation of fragile X syndrome, including mild mental retardation. He had a methylated full mutation of two predominant sizes in all 12 tissues analyzed, including three regions of the brain. The male carrier of a premutation (GC) was clinically unaffected, and the mutation was the same size in all 14 tissues examined including seven regions of the brain. Therefore, both cases demonstrated lack of inter-tissue heterogeneity, suggesting strong somatic stability after the period of expansion to the observed mutation size(s). Also, both cases showed consistency between clinical phenotype and mutation characteristics in the brain.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10331600

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  19 in total

1.  Epigenetics in the human brain.

Authors:  Isaac Houston; Cyril J Peter; Amanda Mitchell; Juerg Straubhaar; Evgeny Rogaev; Schahram Akbarian
Journal:  Neuropsychopharmacology       Date:  2012-05-30       Impact factor: 7.853

2.  Expanded CTG repeat demarcates a boundary for abnormal CpG methylation in myotonic dystrophy patient tissues.

Authors:  Arturo López Castel; Masayuki Nakamori; Stephanie Tomé; David Chitayat; Geneviève Gourdon; Charles A Thornton; Christopher E Pearson
Journal:  Hum Mol Genet       Date:  2010-11-01       Impact factor: 6.150

3.  Methylation mosaicism of 5'-(CGG)(n)-3' repeats in fragile X, premutation and normal individuals.

Authors:  B Genç; H Müller-Hartmann; M Zeschnigk; H Deissler; B Schmitz; F Majewski; A von Gontard; W Doerfler
Journal:  Nucleic Acids Res       Date:  2000-05-15       Impact factor: 16.971

4.  An origin of DNA replication in the promoter region of the human fragile X mental retardation (FMR1) gene.

Authors:  Steven J Gray; Jeannine Gerhardt; Walter Doerfler; Lawrence E Small; Ellen Fanning
Journal:  Mol Cell Biol       Date:  2006-11-13       Impact factor: 4.272

5.  Elevated Fmr1 mRNA levels and reduced protein expression in a mouse model with an unmethylated Fragile X full mutation.

Authors:  J R Brouwer; E J Mientjes; C E Bakker; I M Nieuwenhuizen; L A Severijnen; H C Van der Linde; D L Nelson; B A Oostra; R Willemsen
Journal:  Exp Cell Res       Date:  2006-10-13       Impact factor: 3.905

6.  Longitudinal changes in intellectual development in children with Fragile X syndrome.

Authors:  Scott S Hall; David D Burns; Amy A Lightbody; Allan L Reiss
Journal:  J Abnorm Child Psychol       Date:  2008-03-18

7.  Recommendations from multi-disciplinary focus groups on cascade testing and genetic counseling for fragile X-associated disorders.

Authors:  Allyn McConkie-Rosell; Liane Abrams; Brenda Finucane; Amy Cronister; Louise W Gane; Sarah M Coffey; Stephanie Sherman; Lawrence M Nelson; Elizabeth Berry-Kravis; David Hessl; Sufen Chiu; Natalie Street; Ajay Vatave; Randi J Hagerman
Journal:  J Genet Couns       Date:  2007-05-12       Impact factor: 2.537

8.  CGG allele size somatic mosaicism and methylation in FMR1 premutation alleles.

Authors:  Dalyir I Pretto; Guadalupe Mendoza-Morales; Joyce Lo; Ru Cao; Andrew Hadd; Gary J Latham; Blythe Durbin-Johnson; Randi Hagerman; Flora Tassone
Journal:  J Med Genet       Date:  2014-03-03       Impact factor: 6.318

9.  Epstein-Barr virus transformation of human lymphoblastoid cells from patients with fragile X syndrome induces variable changes on CGG repeats size and promoter methylation.

Authors:  Victoria Bonilla; Francisco Sobrino; Miguel Lucas; Elizabeth Pintado
Journal:  Mol Diagn       Date:  2003

Review 10.  Unstable mutations in the FMR1 gene and the phenotypes.

Authors:  Danuta Loesch; Randi Hagerman
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.